Last --
Change Today 0.00 / 0.00%
Volume 0.0
PFIZER On Other Exchanges
PFIZER is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

pfizer limited (PFIZER) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for PFIZER LIMITED (PFIZER)

Related News

No related news articles were found.

pfizer limited (PFIZER) Related Businessweek News

No Related Businessweek News Found

pfizer limited (PFIZER) Details

Pfizer Limited engages in the manufacture, marketing, trading, and export of pharmaceutical products in India and internationally. The company offers prescription medicines and consumer healthcare products in the areas of anti-allergic, anti-diabetic, antihistamine, anti-infectives, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, GI, multivitamins, neurology, pain/fever/inflammation, pain/inflammation, pediatrics, pediatrics, psychiatry, respiratory, urology, and vitamin/minerals. It sells its products through independent distributors primarily in India. The company was incorporated in 1950 and is headquartered in Mumbai, India. Pfizer Limited is a subsidiary of Pfizer East India BV.

2,417 Employees
Last Reported Date: 10/9/14
Founded in 1950

pfizer limited (PFIZER) Top Compensated Officers

Managing Director, Additional Director, Membe...
Total Annual Compensation: 30.3M
Chief Financial Officer, Head of Finance & Di...
Total Annual Compensation: 12.7M
Executive Director of Technical Operations, W...
Total Annual Compensation: 10.6M
Compensation as of Fiscal Year 2014.

pfizer limited (PFIZER) Key Developments

Vectura Group plc and Pfizer Limited Signs Exclusive Agreement

Vectura Group plc announced that alliance partner Novartis, has confirmed that Pfizer Limited has signed an exclusive agreement to commercialise Ultibro® Breezhaler® (indacaterol /glycopyrronium bromide) and Seebri® Breezhaler®(glycopyrronium bromide) in the United Kingdom.

Pfizer Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Pfizer Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 2,398.5 million against INR 2,375.3 million for the same period of last year. Profit from operations before other income, finance costs and exceptional items was INR 599.9 million against INR 427 million for the same period of last year. Profit from ordinary activities before tax was INR 699.5 million against INR 731.1 million for the same period of last year. Net profit from ordinary activities after tax was INR 461.5 million or INR 15.47 per basic and diluted share against INR 476.3 million or INR 15.96 per basic and diluted share for the same period of last year.

Pfizer Limited to Report Q1, 2015 Results on Jul 24, 2014

Pfizer Limited announced that they will report Q1, 2015 results on Jul 24, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ:IN 1,649.10 INR +42.80

PFIZER Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,099 INR +10.30
Array BioPharma Inc $3.65 USD -0.22
Merit Medical Systems Inc $15.19 USD +0.126
Sagent Pharmaceuticals Inc $31.65 USD -0.25
Spectrum Pharmaceuticals Inc $7.54 USD -0.11
View Industry Companies

Industry Analysis


Industry Average

Valuation PFIZER Industry Range
Price/Earnings 21.5x
Price/Sales 4.2x
Price/Book 7.2x
Price/Cash Flow 20.7x
TEV/Sales 4.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER LIMITED, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at